References
- Bianchini R., Vecchio C. Modified release bead coated with cellulose derivatives by the pan coating technique. Bolletina Chimico Farmaceutica 1987; 126: 441–446
- Cakiryildiz C., Mehta P.J., Rahmen W., Schoenleber D. Dissolution studies with a multichannel continuous-flow apparatus. Journal of Pharmaceutical Science 1975; 64: 1692–1695
- Del Favero A. Antiinflammatory analgesics and drugs used in rheumatoid arthritis and gout. Side Effects of Drugs, M. N. G. Dukes, L. Beeley. Elsevier, Amsterdam 1988; 80, Ann. 12
- Hagen K.J. New development in delayed-release delivery. Chemist and Druggist 1982; 218: 382
- Houghton G.W., Dennis M.J., Rigler E.D., Parsons R.L. Comparative pharmacokinetics of ketoprofen derived from single oral dose of ketoprofen capsules. Biopharmacology of Drug Disposition 1984a; 5: 203–209
- Houghton G.W., Dennis M.J., Templeton R., Calver R.M., Cresswell D.G. Pharmacokinetic study of retarded dose of a new controlled release form of ketoprofen (Oruvail). International Journal of Clinical Pharmacology and Therapeutic Toxicology 1984b; 22: 1131–1132
- Houghton G.W., Dennis M.J., Rigler E.D., Parsons R.L. Urinary pharmacokinetics of orally administered ketoprofen in man. European Journal of Drug Metabolism and Pharmacokinetics 1984c; 9: 201–204
- Kitamori N., Makino T. Effect of drug content and drug particle size during compression. Journal of Pharmacy and Pharmacology 1979; 31: 501–507
- Lang B. In vitro release rate as a standard requirement. Pharmazie 1971; 26: 661–664
- Marcolongo R., Rubegni M., Prouvedi D. Double blind, interpatient comparison of plain and slow release ketoprofen in Osteoarthritis. International Journal of Clinical Pharmacology and Therapeutic Toxicology 1981; 22: 337–381
- Mortada S.A.M., El-Egaky M.A., Motawi A.M., El-Khodery K. Preparation and release kinetics of hydrochlorothiazide from butyl half-ester of PVM/MA microcapsules. Journal of Microencapsultion 1988; 5: 203–217, Röhm-Pharma, GmbH, Darmstadt, Germany, Technical data pamphlet (Info RS-3/e).
- Rogers J.A., Anderson M.J. Physical characteristics and dissolution profiles of ketoprofen-urea solid dispersion. Pharmaceutica Acta Helvetiae 1982; 57: 276–281
- Russell A.S., Labelle J. Double blind crossover study of ketoprofen enteric coated and ketoprofen non-enteric coated tablets in patients with ankylosis spondylitis, osteoarthritis and rheumatoid arthritis. Journal of Current Therapeutic Research and Clinical Experimentation 1983; 33: 185–199
- Takayama K., Nambu N., Nagai T. Factors affecting the dissolution of ketoprofen from solid dispersions in various water soluble polymers. Chemical and Pharmaceutical Bulletin 1982; 30: 3013–3016
- Toft B., Christophersen J., Christensen N., Hasselsoe G., Jakobsen G. Double blind crossover study of sustained release tablet of ketoprofen and normal ketoprofen capsules in the treatment of patients with osteoarthritis. Current Medical Research Opinion 1985; 9: 708–712
- Train D. Some aspects of the property of the angle of repose of powder. Journal of Pharmacy and Pharmacology 1958; 10: 127–135T
- Williams M.J., Labelle J.L., Farget J.P. Double blind crossover study of ketoprofen enteric and nonenteric coated tablets in rheumatoid arthritis. Current Therapeutic Research and Clinical Experimentation 1982; 31: 913–921
- Zecchi V., Tartarini A., Orienii I., Rodriguez L., Cini M., Conte U. Chemical properties—dissolution of nonsteroidal antiinflammatory drugs. II—Factors affecting the release of NSAID from monoliths. Pharmaceutica Acta Helvetiae 1986; 61: 322–325